» Articles » PMID: 29259717

The Crystal-induced Activation of NLRP3 Inflammasomes in Atherosclerosis

Overview
Journal Inflamm Regen
Publisher Biomed Central
Date 2017 Dec 21
PMID 29259717
Citations 24
Authors
Affiliations
Soon will be listed here.
Abstract

Atherosclerosis is an inflammatory disease, which is accompanied by the deposition of cholesterol-rich lipids and the infiltration of macrophages. Other well-known features of atherosclerotic lesions include the deposition of cholesterol crystals and calcium phosphate crystals; however, their pathophysiological role remains unclear. Recent studies suggest that cholesterol crystals play a pivotal role in activation of NLRP3 inflammasomes, which regulate caspase-1 activation and the subsequent processing of IL-1β, in atherosclerotic lesions. NLRP3 inflammasomes are essential for the initiation of vascular inflammation during the progression of atherosclerosis. Therefore, the regulatory mechanisms of NLRP3 inflammasomes are regarded as potential targets for atherosclerosis treatment. Here, we review the current knowledge regarding the role of NLRP3 inflammasomes in the progression of atherosclerosis and the prospects for therapeutic approaches targeting NLRP3 inflammasomes.

Citing Articles

The Anti-Inflammatory Potential of Tricyclic Antidepressants (TCAs): A Novel Therapeutic Approach to Atherosclerosis Pathophysiology.

Eslami M, Monemi M, Nazari M, Azami M, Shariat Rad P, Oksenych V Pharmaceuticals (Basel). 2025; 18(2).

PMID: 40006011 PMC: 11858810. DOI: 10.3390/ph18020197.


Therapeutic potential of seaweeds and their biofabricated nanoparticles in treating urolithiasis: A review.

Raj C T D, Palaninathan V, Kandaswamy S, Kumar V, James R Heliyon. 2025; 11(1):e41132.

PMID: 39802010 PMC: 11720914. DOI: 10.1016/j.heliyon.2024.e41132.


The effect of NLRP3 inflammasome on cardiovascular prognosis in patients with acute coronary syndrome.

Mo D, Liang M, Xu L, Li T, Han Q, Chen C Sci Rep. 2025; 15(1):1187.

PMID: 39775137 PMC: 11707183. DOI: 10.1038/s41598-024-85041-4.


Macropinocytosis enhances foamy macrophage formation and cholesterol crystallization to activate NLRP3 inflammasome after spinal cord injury.

Zhang C, Zhao S, Huang Z, Xue A, Liu H, Dai S Redox Biol. 2024; 79():103469.

PMID: 39700693 PMC: 11723182. DOI: 10.1016/j.redox.2024.103469.


The Role of Inflammasome in Abdominal Aortic Aneurysm and Its Potential Drugs.

Pi S, Xiong S, Yuan Y, Deng H Int J Mol Sci. 2024; 25(9).

PMID: 38732221 PMC: 11084561. DOI: 10.3390/ijms25095001.


References
1.
Song H, Liu B, Huai W, Yu Z, Wang W, Zhao J . The E3 ubiquitin ligase TRIM31 attenuates NLRP3 inflammasome activation by promoting proteasomal degradation of NLRP3. Nat Commun. 2016; 7:13727. PMC: 5155141. DOI: 10.1038/ncomms13727. View

2.
Baroja-Mazo A, Martin-Sanchez F, Gomez A, Martinez C, Amores-Iniesta J, Compan V . The NLRP3 inflammasome is released as a particulate danger signal that amplifies the inflammatory response. Nat Immunol. 2014; 15(8):738-48. DOI: 10.1038/ni.2919. View

3.
Zhou R, Yazdi A, Menu P, Tschopp J . A role for mitochondria in NLRP3 inflammasome activation. Nature. 2010; 469(7329):221-5. DOI: 10.1038/nature09663. View

4.
Karasawa T, Kawashima A, Usui F, Kimura H, Shirasuna K, Inoue Y . Oligomerized CARD16 promotes caspase-1 assembly and IL-1β processing. FEBS Open Bio. 2015; 5:348-56. PMC: 4420773. DOI: 10.1016/j.fob.2015.04.011. View

5.
Franchi L, Amer A, Body-Malapel M, Kanneganti T, Ozoren N, Jagirdar R . Cytosolic flagellin requires Ipaf for activation of caspase-1 and interleukin 1beta in salmonella-infected macrophages. Nat Immunol. 2006; 7(6):576-82. DOI: 10.1038/ni1346. View